While Syneos Health, Inc. (NASDAQ:SYNH) might not be the most widely known stock at the moment, it maintained its current share price over the past couple of month on the NASDAQGS, with a relatively tight range of US$41.53 to US$42.77. However, does this price actually reflect the true value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Syneos Health's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Syneos Health

What's The Opportunity In Syneos Health?

Great news for investors – Syneos Health is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is $61.40, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Syneos Health's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

What does the future of Syneos Health look like?

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to more than double over the next couple of years, the future seems bright for Syneos Health. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? Since SYNH is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you've been keeping an eye on SYNH for a while, now might be the time to enter the stock. Its buoyant future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy SYNH. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed buy.